Product

TCR1672

Aliases

TCR1672 tablet

1 clinical trial

1 indication

Indication

Refractory Chronic Cough

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase Ib/II Clinical Study to Evaluate the Efficacy, Safety and Pharmacokinetics of TCR1672 Tablets in Patients With Refractory Chronic Cough

Status: Not yet recruiting, Estimated PCD: 2024-10-01